EN-374

· Ensoma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EN-374, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease [Phase 1, Phase 2]